UCB | Rörelsekostnader



Operating Expenses Ändra Datum
Alcon AG USD 2.11B 15M 2024-12
Almirall EUR 195.38M 68.92M 2024-06
Amarin USD 67.47M 549K 2024-09
argenx SE USD 635.37M 62.66M 2024-12
AstraZeneca USD 12.86B 2.06B 2024-12
Bayer EUR 8.2B 5.59B 2024-12
Galapagos EUR 138.22M 24.07M 2024-12
Genmab DKK 4.25B 812M 2024-12
GlaxoSmithKline GBP 7.42B 402M 2024-12
GRIFOLS EUR 1.6B 128.03M 2024-12
Hikma Pharmaceutical USD 1.24B 87M 2024-06
Lonza CHF 2.52B 776M 2024-06
Merck EUR 4.22B 52M 2024-12
Novartis USD 11.28B 1.73B 2024-12
Orion EUR 341.7M 72.4M 2024-12
Recordati EUR 394.73M 34.25M 2024-09
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 10.07B 969M 2024-09
UCB EUR 1.23B 1.31B 2024-06
Unibail Rodamco EUR 1.18B 844M 2024-12



UCB Rörelsekostnader - Aktuella värden, historiska data, prognoser, statistik, diagram och ekonomisk kalender - Apr 2025.